
Beside Oncology, radiotherapeutics can also be of interest in the treatment of rheumatoid polyarthritis. Radionuclide synovectomy (Radiosynovectomy – RSV) is a minimally invasive method of treating persistent join inflammation. Radiosynovectomy is safe, well tolerated and efficacious. About 70–80% of patients respond well to the therapy. However, the therapeutic effects are considerably worse in patients with co-existent osteoarthritis and advanced joint degeneration. Despite its advantages, Radionuclide synovectomy is not performed as often as it could be, so greater knowledge and understanding of this method are needed.
Sources: NIH.gov
Approved treatments
Clinical trials
- N/A
Patient associations
TBD